Abbott plans to launch device that can detect traumatic brain injury

It's designed to collect blood samples and test protein level in blood to assess extent of injury

US-headquartered healthcare major Abbott plans to launch a unique device in India that can detect traumatic brain injury using a blood test. 

Sharon Bracken, President for the Point of Care at Abbott, says the company is developing a blood-based biomarker test to run on its portable i-STAT device. 

The pharma giant claims this can identify problems such as concussion, a form of mild traumatic head injury. Currently, the company’s point of care tests include those for haemoglobin and kidney.

Abbott is initiating its trials in the US market this year after which the device will be brought to India. “The device will be